RxDoctor Payments Data

Karan Nealen

Family · Ebensburg, PANPI 1063056836

Payments from drug & device makers

$5,286in general payments, 2019–2025

Across 301 payments — averaging $17.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$550
  • AstraZeneca$416
  • Phathom Pharmaceuticals, Inc.$353
  • Tactile Systems Technology Inc$349
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$276
  • plus $2K from 19 others

What the payments were for

  • Food & beverage$5,286100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,286 in reported general payments places this provider in the 90th percentile of 4,717 family providers in Pennsylvania.

See all family providers in Pennsylvania

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter20$14,544
Pantoprazole Sodium75$1,228
Potassium Chloride26$1,003
Atorvastatin Calcium47$938
Rosuvastatin Calcium48$895
Tamsulosin Hcl23$702
Levothyroxine Sodium54$673
Losartan Potassium40$598
Metoprolol Succinate23$586
ClopidogrelClopidogrel Bisulfate20$517
Omeprazole25$507
SynthroidLevothyroxine Sodium11$497
Amlodipine Besylate57$486
Montelukast Sodium17$486
Venlafaxine Hcl ErVenlafaxine Hcl17$472

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta$134$14,54420 claims
AbbVieSynthroid$1,352$49711 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,717 family providers in Pennsylvania.

Other family in Ebensburg

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →